The estimated Net Worth of Venture Partners Ix, Llcarc... is at least $7.83 Milión dollars as of 16 October 2019. Venture Llcarc owns over 1,000,000 units of Vir Biotechnology Inc stock worth over $7,830,000 and over the last 5 years Venture sold VIR stock worth over $0.
Venture has made over 1 trades of the Vir Biotechnology Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Venture bought 1,000,000 units of VIR stock worth $20,000,000 on 16 October 2019.
The largest trade Venture's ever made was buying 1,000,000 units of Vir Biotechnology Inc stock on 16 October 2019 worth over $20,000,000. On average, Venture trades about 1,000,000 units every 0 days since 2019. As of 16 October 2019 Venture still owns at least 1,000,000 units of Vir Biotechnology Inc stock.
You can see the complete history of Venture Llcarc stock trades at the bottom of the page.
Over the last 5 years, insiders at Vir Biotechnology Inc have traded over $197,171,926 worth of Vir Biotechnology Inc stock and bought 6,960,011 units worth $139,246,875 . The most active insiders traders include Norbert W Bischofberger, Endurance (Cayman) Ltd Sb I... a Kristina Burow. On average, Vir Biotechnology Inc executives and independent directors trade stock every 7 days with the average trade being worth of $478,115. The most recent stock trade was executed by Janet Napolitano on 9 September 2024, trading 12,190 units of VIR stock currently worth $95,082.
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Vir Biotechnology Inc executives and other stock owners filed with the SEC include: